T1	Drug_or_compound 0 3	UFT
T2	Pathological_formation 67 87	renal cell carcinoma
T4	Drug_or_compound 139 142	UFT
T5	Drug_or_compound 184 191	tegafur
T6	Drug_or_compound 193 195	FT
T7	Drug_or_compound 201 207	uracil
T8	Drug_or_compound 1371 1394	fluorinated pyrimidines
T9	Drug_or_compound 449 452	UFT
T10	Cell 461 471	RENCA cell
T13	Cell 591 602	RENCA cells
T14	Drug_or_compound 629 632	UFT
T17	Drug_or_compound 689 703	5-fluorouracil
T18	Drug_or_compound 705 709	5-FU
T19	Drug_or_compound 715 728	doxifluridine
T20	Drug_or_compound 782 784	FT
T21	Drug_or_compound 814 817	UFT
T22	Drug_or_compound 819 825	uracil
T24	Drug_or_compound 911 936	gamma-hydroxybutyric acid
T25	Drug_or_compound 941 960	gamma-butyrolactone
T26	Drug_or_compound 981 983	FT
T29	Drug_or_compound 1222 1225	UFT
T30	Drug_or_compound 1278 1282	5-FU
T31	Drug_or_compound 1306 1309	UFT
T35	Drug_or_compound 1513 1517	5-FU
T36	Drug_or_compound 1569 1594	gamma-hydroxybutyric acid
T37	Drug_or_compound 1599 1618	gamma-butyrolactone
T38	Drug_or_compound 1620 1623	UFT
T16	Pathological_formation 287 293	cancer
T28	Organism_substance 1146 1151	blood
T32	Organism_substance 1497 1502	blood
T1000	Organism 60 66	murine
T1001	Organism 132 136	mice
T1002	Organism 294 302	patients
T1003	Organism 608 612	mice
T3	Blood_vessel_development 36 48	angiogenesis
T11	Blood_vessel_development 480 492	angiogenesis
T12	Blood_vessel_development 527 539	angiogenesis
T15	Blood_vessel_development 649 661	angiogenesis
T23	Blood_vessel_development 868 880	angiogenesis
T27	Blood_vessel_development 1002 1014	angiogenesis
T33	Blood_vessel_development 1325 1337	angiogenesis
*	Equiv T17 T18
*	Equiv T5 T6
T34	Negative_regulation 24 31	inhibit
E1	Negative_regulation:T34 Theme:E21 Cause:T1
T39	Positive_regulation 49 56	induced
E2	Positive_regulation:T39 Cause:T2 Theme:E21
T40	Planned_process 281 286	treat
E3	Planned_process:T40 Instrument:T4 Theme:T1002
T41	Negative_regulation 428 445	inhibitory effect
E4	Negative_regulation:T41 Theme:E22 Cause:T9
T42	Positive_regulation 472 479	induced
E5	Positive_regulation:T42 Cause:T10 Theme:E22
T43	Positive_regulation 543 550	induced
E6	Positive_regulation:T43 Theme:E23 Cause:E7
T44	Planned_process 554 566	implantation
E7	Planned_process:T44 Instrument:T13 Theme:T1003
T45	Negative_regulation 662 679	inhibitory effect
E8	Negative_regulation:T45 Cause:T14 Theme:E24
T46	Negative_regulation 739 748	effective
E9	Negative_regulation:T46 Theme:E24 Cause:T19
E10	Negative_regulation:T46 Theme:E24 Cause:T17
T47	Regulation 835 846	ineffective
E11	Regulation:T47 Cause:T22 Theme:E28
A1	Negation E11
T48	Negative_regulation 1015 1032	inhibitory effect
E12	Negative_regulation:T48 Theme:E26 Cause:T25
E13	Negative_regulation:T48 Theme:E26 Cause:T24
T49	Positive_regulation 1041 1050	amplified
E14	Positive_regulation:T49 Theme:T25
T50	Planned_process 1074 1086	administered
E15	Planned_process:T50 Instrument:T25
E16	Positive_regulation:T49 Theme:T24
E17	Planned_process:T50 Instrument:T24
T51	Planned_process 1204 1218	administration
E18	Planned_process:T51 Instrument:T29
T52	Negative_regulation 1338 1355	inhibitory effect
E19	Negative_regulation:T52 Theme:E27 Cause:T31
E20	Negative_regulation:T52 Theme:E27 Cause:T8
E21	Blood_vessel_development:T3 
E22	Blood_vessel_development:T11 
E23	Blood_vessel_development:T12 
E24	Blood_vessel_development:T15 
E25	Blood_vessel_development:T23 
E26	Blood_vessel_development:T27 
E27	Blood_vessel_development:T33 
T53	Negative_regulation 854 864	inhibition
E28	Negative_regulation:T53 Theme:E25
T54	Planned_process 325 337	chemotherapy
E29	Planned_process:T54 Theme:T1002
